EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Introduction of DNA ‐ HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget

Felipe Polido Urbano iD, Gabriel Russo Cury iD, Caio Rodrigo Dos Santos iD, Daniel José Castilho da Silva iD, José Cândido Caldeira Xavier-Júnior iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70594 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Felipe Polido Urbano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Medical School, Salesian Catholic University Center Auxilium (UNISALESIANO), Araçatuba, São Paulo, Brazil. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Papillomavirus Infections, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the financial applicability of the DNA‐HPV test for cervical cancer screening in a developing country like Brazil.

Methods

This was a retrospective, observational study based on documentary data, conducted to assess the cost‐effectiveness of cervical cancer screening strategies in Brazil. The study used national cervical cancer screening data collected between January 1 and December 31, 2020 for women between 25 and 64 years old, performing a cost‐effectiveness assessment of two different screening tests. No sensitivity analysis was conducted due to the descriptive nature of this preliminary cost assessment.

Results

Based on the cervical smear, the Brazilian protocol has an estimated cost of US$117.5 million. In contrast, when using the HPV DNA test, the estimated cost is US$1.39 billion.

Conclusion

The current use of the cervical smear is the least expensive and the only one that aligns with Brazil's financial resources allocated to health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsEarly Detection of CancerPapillomavirus InfectionsMass ScreeningHuman Papillomavirus DNA TestsHumansFemaleBrazilAdultRetrospective StudiesMiddle AgedCost-Benefit AnalysisVaginal SmearsDNA, Viral

Stichwörter der Autor:innen

cervical cancercervical smearscreening programs

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Pathology Department, Medical School, Salesian Catholic University Center Auxilium (UNISALESIANO), Araçatuba, São Paulo, Brazil.
  • Pathology Department, Institute of Araçatuba, Araçatuba, São Paulo, Brazil.
  • Pathology Department, São Paulo State University, UNESP, Botucatu, São Paulo, Brazil.

ORCID-Profile: Felipe Polido Urbano, Gabriel Russo Cury, Caio Rodrigo Dos Santos, Daniel José Castilho da Silva, José Cândido Caldeira Xavier-Júnior

Zitieren

APA

Urbano, F. P., Cury, G. R., Dos Santos, C. R., da Silva, D. J. C., & Xavier-Júnior, J. C. C. (2025). Introduction of DNA ‐ HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70594

Vancouver

Urbano FP, Cury GR, Dos Santos CR, da Silva DJC, Xavier-Júnior JCC. Introduction of DNA ‐ HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70594

BibTeX
@article{Urbano2025,
  author = {Urbano, Felipe Polido and Cury, Gabriel Russo and Dos Santos, Caio Rodrigo and da Silva, Daniel José Castilho and Xavier-Júnior, José Cândido Caldeira},
  title = {Introduction of DNA ‐ HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70594}
}
Kostenlos starten →